PDGFRB and systemic sclerosis: The platelet-derived growth factor (PDGF) contributes to the pathogenesis of SSc by activating the proliferation of fibroblasts and SMCs via two tyrosine-kinase receptors, PDGFRα and PDGFRβ [130].